Drug-related gingival hyperplasia
Drug-related Gingival Hyperplasia
Drug-related gingival hyperplasia (pronunciation: /ˈdrʌɡ rɪˈleɪtɪd ˈdʒɪndʒɪvəl haɪpərˈpleɪziə/) is a condition characterized by an overgrowth or enlargement of the gums that is induced by certain medications.
Etymology
The term "gingival hyperplasia" is derived from the Greek words "hyper" meaning over or more, and "plasia" meaning formation. "Gingival" refers to the gums, and "drug-related" indicates that the condition is induced by medication.
Causes
Drug-related gingival hyperplasia is most commonly associated with three types of medications: anticonvulsants, calcium channel blockers, and immunosuppressants. The exact mechanism by which these drugs cause gingival overgrowth is not fully understood, but it is believed to involve changes in the connective tissue metabolism in the gums.
Symptoms
The primary symptom of drug-related gingival hyperplasia is an enlargement of the gums. This can range from mild to severe and can affect any part of the gums. Other symptoms may include bleeding, tenderness, and difficulty in chewing.
Treatment
Treatment for drug-related gingival hyperplasia typically involves managing the underlying cause, which is the medication causing the overgrowth. This may involve changing the medication or adjusting the dosage. In severe cases, surgical intervention may be required to remove the excess gum tissue.
Related Terms
See Also
External links
- Medical encyclopedia article on Drug-related gingival hyperplasia
- Wikipedia's article - Drug-related gingival hyperplasia
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski